Acyclovir-loaded chitosan nanoparticles for ocular delivery

Asian Journal of Pharmaceutics

Volumn 4, Issue 4, 2010, Pages 220-226

  Rajendran, N ^a   Natrajan, R ^a   Kumar, R ^a   Selvaraj, S ^b  

^a SWAMY VIVEKANANDHA COLLEGE OF PHARMACY   (India)

^b Cherraan's College of Pharmacy   (India)

Author keywords

Acyclovir; chitosan; ionic gelation method; ocular delivery nanoparticles

Indexed keywords

ACICLOVIR; CHITOSAN; NANOPARTICLE; TRIPOLYPHOSPHATE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; GELATION; INFRARED SPECTROSCOPY; LOADING TEST; NANOENCAPSULATION; OPHTHALMIC DRUG DELIVERY SYSTEM; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

EID: 79951998605     PISSN: 09738398     EISSN: 1998409X     Source Type: Journal    
DOI: 10.4103/0973-8398.76749     Document Type: Article

References (28)

1. Jabs DA. Acyclovir for recurrent herpes simplex virus ocular disease. N Engl J Med 1998;339:300-6.
2. Ohashi Y. Treatment of herpetic keratitis with acyclovir: Benefits and problems. Ophthalmologica 1997;211:29-32. (Pubitemid 27110064)
3. Aylward GW, Claoue CM, Marsh RJ, Yasseem N. Influence of oral acyclovir on ocular complications of herpes zoster ophthalmicus. Eye 1994;8:70-4. (Pubitemid 24141231)
4. rd ed. Boston, Massachusetts: Little Brown; 1994. p. 183-214.
5. Taskintuna I, Banker AS, Flores-Aguilar M, Bergeron-Lynn G, Aldern KA, Hostetler KY, et al. Evaluation of a novel lipid prodrug for intraocular drug delivery: Effect of acyclovir diphosphate dimyristoylglycerol in a rabbit model with herpes simplex virus-1 retinitis. Retina 1997;17:57-64. (Pubitemid 27091651)
6. Genta I, Conti B, Perugini P, Pavanetto F, Spadaro A, Puglisi G. Bioadhesive microspheres for ophthalmic administration of acyclovir. J Pharma Pharmacol 1997;49:737-42. (Pubitemid 27386891)
7. Calvo P, Alonso MJ, Vila-Yato JL, Robinson JR. Improved ocular bioavailability of indomethacin by novel oculardrug carriers. J Pharm Pharmacol 1996;48:1147-52. (Pubitemid 126449485)
8. De Campos M, Sanchez A, Alonso MJ. Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm 2001;224:159-68. (Pubitemid 32706495)
9. Knapczyk J, Krówczynski L, Krzck J, Brzeski M, Nirnberg E, Schenk D, et al. Requirements of chitosan for pharmaceutical and biomedical applications. In: Skak-Braek G, Anthonsen T, Sandford P, editors. Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications. London: Elsevier; 1989. p. 657-63.
10. Artursson P, Lindmark T, Davis SS, Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 1994;11:1358-61. (Pubitemid 24287420)
11. Giannavola C, Bucolo C, Maltese A, Paolino D, Vandelli MA, Puglisi G, et al. Influence of preparation conditions on acyclovir-loaded polyd,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability. Pharma Res 2003;20:584-90. (Pubitemid 36438901)
12. de Campos AM, Diebold Y, Carvalho EL, Sánchez A, Alonso MJ. Chitosan nanoparticles as new ocular drug delivery systems: In vitro Stability, in vivo fate, and cellular toxicity. Pharm Res 2004;21:803-10.
13. Enríquez de Salamanca A, Diebold Y, Calonge M, García-Vazquez C, Callejo S, Vila A, et al. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance. Invest Ophthalmol Vis Sci 2006;47:1416-25. (Pubitemid 46780748)
14. Lurui Qin Zhu Wall. Acyclovir chitosan nanoparticles in rabbit's eyes. Pharm Clin Res 2007;15:1.
15. Calvo P, Vila-Jato JL, Alonso MJ. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm 1997a;53:41-50. (Pubitemid 27283332)
16. Yadav KS, Sathish CS, Shivkumar HG. Preparation and evaluation of chitosan -Poly(Acrylic acid)Hydrogels as stomach specific delivery for amoxicillin and metronidazole. Indian J Pharm Sci 2007;69:91-5. (Pubitemid 46732845)
17. Alonso MJ, Sanchez A. Biodegradable nanoparticles as new transmucosal drug carrier. Carrier Based Drug Delivery 2004;879:283-95.
18. Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. Invitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 1992;78:43-8.
19. Feltt O, Buri P, Gurny R. Chitosan; a unique polysaccharide for drug delivery. Drug Dev Ind Pharm 1998;24:979-93. (Pubitemid 28460237)
20. Desai MP, Labhasetwar V, Amidon GL Levy RJ. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size. Pharmacol Res 1996;13:1838-45. (Pubitemid 27034116)
21. Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polm Sci 1997b;63:125-32. (Pubitemid 127613982)
22. Mosqueira VC, Legrand P, Gref R, Barratt G. In-vitro release kinetic studies of PEG-modified nanocapsules and nanospheres loaded with a lipophilic drug: Halofantrine base. Control Rel Bioact Mater 1999;26:1074-5.
23. Mosqueira VC, Legrand P, Pinto-Alphandary H, Puisieux F, Barratt G. Poly (D, L-lactide) nanocapsules prepared by a solvent displacement process: Influence of the composition on physicochemical and structural properties. J Pharm Sci 2000;89:614-26.
24. Wu Y, Yang W, Wang C, Hu J, Fu S. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm 2005;295:235-45. (Pubitemid 40558806)
25. Zhou SB, Deng XM, Li X. Investigation on a novel core-coated microspheres protein delivery system. J Control Release 2001;75:27-36. (Pubitemid 32635194)
26. Fernandez-Urrusuno R, Calvo P, Remunan-Lopez C, Vila-Jato JL, Alsono MJ. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm Res 1999;16:1576-81. (Pubitemid 29510555)
27. Lehr CM, Bouwstra JA, Schacht E, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 1992;78:43-8.
28. Gundu ZK, O Zdemir O. Topical cyclosporine treatment of keratoconjunctivitis sicca in secondary Sjogren's syndrome. Acta Ophthalmol 1994;72:438-42.